Skip to content
Wenlo
Sign in
← Markets

Medtronic plc

Michael Marinaro (President) reports MDT insider transactions

4MDTFiled Nov 4, 2026, 4:37 PM ET· Period Nov 2, 2026

AI-generated summary

Michael Marinaro, President of Medtronic plc, received a grant of 6,547 ordinary shares, 16,367 performance share units, and 42,994 stock options on November 2, 2026. Following these transactions, the reporting person directly holds 113,353 ordinary shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Michael Marinaro · President
DateTransactionSharesPriceValueHeld afterOwnership
Nov 2, 2026A · grantFootnotes F1, F2+6,547$0.00$0.00113,353Direct
Nov 2, 2026A · grantPerformance Share UnitsFootnotes F3, F4, F5+16,367$0.00$0.0016,367Direct
Nov 2, 2026A · grantStock Option (Right to Buy)Footnotes F6+42,994$0.00$0.0042,994Direct
Footnotes
  1. F1 Represents restricted stock units that vest 100% on August 3, 2029.
  2. F2 Includes 890 shares acquired through dividend reinvestment since the last report filed by the reporting person.
  3. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  4. F4 Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
  5. F5 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 16,367 shares will be issued. If maximum performance metrics are achieved, 39,281 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  6. F6 These options become exercisable at the rate of 25% of the shares granted per year beginning on August 3, 2027.

More MDT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.